Literature DB >> 13143088

Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria.

A G BEARN, H G KUNKEL.   

Abstract

Entities:  

Keywords:  AMINO ACIDS/in urine; COPPER/metabolism; HEPATOLENTICULAR DEGENERATION/metabolism in; URINE

Mesh：

Substances：

Year:  1954        PMID： 13143088      PMCID： PMC1072519          DOI： 10.1172/JCI102912

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  The amino acid content of the blood and urine in Wilson's disease.

Authors:  W H STEIN; A G BEARN; S MOORE
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

2.  Genetic and biochemical aspects of Wilson's disease.

Authors:  A G BEARN
Journal:  Am J Med       Date:  1953-10       Impact factor: 4.965

3.  Effect of chelating agent on urinary lead excretion; comparison of oral and intravenous administration.

Authors:  J B SIDBURY; J C BYNUM; L L FETZ
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

4.  Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states.

Authors:  M E LAHEY; C J GUBLER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1953-04       Impact factor: 14.808

5.  The metabolic disorder in hepato-lenticular degeneration.

Authors:  W B MATTHEWS; M D MILNE; M BELL
Journal:  Q J Med       Date:  1952-10

6.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

7.  Oxidase reactions in human plasma caused by coeruloplasmin.

Authors:  C G HOLMBERG; C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

8.  Zone electrophoresis in a starch supporting medium.

Authors:  H G KUNKEL; R J SLATER
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

9.  The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).

Authors:  D DENNY-BROWN; H PORTER
Journal:  N Engl J Med       Date:  1951-12-13       Impact factor: 91.245

10.  The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration).

Authors:  L L UZMAN; B HOOD
Journal:  Am J Med Sci       Date:  1952-04       Impact factor: 2.378
View more
  30 in total

1.  BASAL COPPER EXCRETION IN WILSON'S DISEASE.

Authors:  C B WARREN; P M BROUGHTON
Journal:  Arch Dis Child       Date:  1964-06       Impact factor: 3.791

2.  Wilson's disease.

Authors:  C B WARREN; P M BROUGHTON
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

3.  Effect of estrogens on copper metabolism in Wilson's disease.

Authors:  J L GERMAN; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

4.  Liver disease.

Authors:  F W HOFFBAUER
Journal:  Am J Dig Dis       Date:  1959-10

5.  Hepato-lenticular degeneration.

Authors:  L R COKE; E G SHAW
Journal:  Can Med Assoc J       Date:  1955-12-15       Impact factor: 8.262

6.  Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

Authors:  J A BUSH; J P MAHONEY; H MARKOWITZ; C J GUBLER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

7.  [Research on copper metabolism in several forms of schizophrenia].

Authors:  M OZEK
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1957

8.  Renal function in Wilson's disease.

Authors:  A G BEARN; T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

9.  CIRCUMSCRIBED myxoedema.

Authors: 
Journal:  Br Med J       Date:  1957-08-03

10.  Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.

Authors:  I H SCHEINBERG; A G MORELL
Journal:  J Clin Invest       Date:  1957-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.